Inicio › Linfoma difuso de células B grandes › Texas › Dallas
Ensayos clínicos de Linfoma difuso de células B grandes en Dallas, TX
13 estudios para Linfoma difuso de células B grandes buscan participantes en centros de Dallas y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
ReclutandoFase 2
- UT Southwestern Medical Center ( Site 0190), Dallas
A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
ReclutandoFase 3
- Texas Oncology - DFW ( Site 8000), Dallas
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
ReclutandoFase 1
- Texas Oncology - DFW (Sammons CC), Dallas
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
ReclutandoFase 1
- University of Texas Southwestern, Dallas
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
ReclutandoFase 2
- Texas Oncology - Dallas Fort Worth, Dallas
Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma
ReclutandoFase 1/2
- Baylor University Medical Center, Dallas
Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU
ReclutandoEstudio observacional
- UT Southwestern Medical Center, Dallas
DALY II USA/ MB-CART2019.1 for DLBCL
ReclutandoFase 2
- UT Southwestern Medical Center, Dallas
Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma
ReclutandoFase 2
- University of Texas Southwestern Medical Center, Dallas
IOMAB-CAR-T Followed by CAR-T Cell Therapy in R/R DLBCL
ReclutandoFase 1/2
- University of Texas Southwestern Medical Center, Dallas
The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
ReclutandoFase 1/2
- University of Texas(UT) Southwestern-Children's Medical Center, Dallas
A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
ReclutandoFase 1
- University of Texas Southwestern Medical Center, Dallas
Safety and Efficacy of KRT-232 in Combination With Acalabrutinib in Subjects With R/R DLBCL or R/R CLL
ReclutandoFase 1/2
- UT Southwestern Medical Center, Dallas
Ensayos de Linfoma difuso de células B grandes en otras ciudades
- New York City, NY21 estudios
- Baldwin Park, CA19 estudios
- Chicago, IL18 estudios
- Houston, TX17 estudios
- Los Angeles, CA17 estudios
- Milwaukee, WI16 estudios
- Boston, MA16 estudios
- Philadelphia, PA15 estudios
- Portland, OR15 estudios
- Durham, NC14 estudios
- Nashville, TN14 estudios
- Seattle, WA12 estudios
Otros estudios en Dallas
- Cáncer de seno54 estudios
- Cáncer de pulmón de células no pequeñas52 estudios
- Fallo cardíaco43 estudios
- Cáncer metastásico42 estudios
- Cáncer (todos los tipos)38 estudios
- Cáncer de próstata36 estudios
- Cáncer del colon y del recto33 estudios
- Obesidad31 estudios
- Cáncer de ovario28 estudios
- Cáncer de vejiga27 estudios
- Cáncer de pulmón27 estudios
- Cáncer de endometrio25 estudios
De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.